M. Şerban

Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors

Barbara A. Konkle, Liselotte S. Ebbesen, Elisabeth Erhardtsen et al. · Journal of Thrombosis and Haemostasis · 2007 · 325 citations · Full text

Thrombosis, Secondary Prophylaxis, Hematology +10

Anti-Inhibitor Coagulant Complex Prophylaxis in Hemophilia with Inhibitors

Cindy Leissinger, A. Gringeri, Bülent Antmen et al. · New England Journal of Medicine · 2011 · 219 citations · Full text

Genetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: A cohort study

Beáta Tóth, Alexander Mihas, Ewa Bernatowska et al. · Molecular Immunology · 2009 · 67 citations · Full text

Immunohematology, X-linked Agammaglobulinemia, Autoimmune Disease +10

Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity

Johnny Mahlangu, Karin Weldingh, Steven R. Lentz et al. · Journal of Thrombosis and Haemostasis · 2015 · 59 citations · Full text

Clinical Immunology, Molecular Immunology, Immunogenetics +9

Haemophilia Care in Europe: the ESCHQoL study

W. Schramm, A. Gringeri, Rolf Ljung et al. · Haemophilia · 2012 · 54 citations